Research Articles | Page 38 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Clinical and neurophysiological aspects of peripheral neuropathy in patients with myelodysplastic syndromes Nov 2024 British Journal of Haematology Myelodysplastic Syndromes (MDS)
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes May 2024 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes Aug 2024 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Chronic fatigue in myelodysplastic syndromes: Looking beyond anemia Jul 2020 Critical reviews in hematology/oncology Myelodysplastic Syndromes (MDS)
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia Oct 2019 Blood Advances Aplastic Anemia
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation? Jul 2024 HemaSphere Myelodysplastic Syndromes (MDS)
Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL) Jun 2020 Leukemia Myelodysplastic Syndromes (MDS)
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria Jan 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes May 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Calculator-free point-of-care prognostication in myelodysplastic syndromes. Jan 2019 Am J Hematol Myelodysplastic Syndromes (MDS)